Leila Russo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 27, 2024
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial.
Journal: The Journal of clinical investigation
Published: October 06, 2023
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.
Journal: Cancer discovery
Published: December 08, 2020
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes.
Journal: Breast cancer research and treatment
Published: June 16, 2019
ACTN3/ACE genotypes and mitochondrial genome in professional soccer players performance.
Journal: Journal of biological regulators and homeostatic agents
Published: March 25, 2017
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance.
Journal: Breast cancer research and treatment
Published: December 28, 2015
Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: December 15, 2015
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Journal: Breast cancer research and treatment
Published: September 24, 2015
Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 12, 2015
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study.
Journal: Breast cancer research and treatment
Published: October 31, 2013
Adjuvant therapies for special types of breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: October 22, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026